Clinical Trial Update: Node-Sparing Hypofractionated Radiotherapy Plus Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advanced Colon Cancer: A Prospective, Randomized, Phase II Trial [Phase 2]

View source ↗

Summary

Phase II randomized trial evaluating node-sparing hypofractionated radiotherapy plus chemotherapy and a PD-1 inhibitor for high-risk locally advanced colon canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• PD-1 inhibitor

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Neoadjuvant Therapies, Immune Checkpoint Therapy | Phase 2 | Status: RECRUITING